{"title":"Widely Used, Rarely Studied-the Over-the-Counter Sleep Aids","authors":"K. Sexton-Radek","doi":"10.4172/2167-0277.1000e143","DOIUrl":null,"url":null,"abstract":"It is estimated that the some 18% of the population have taken an over-the-counter (OTC) sleep aid with some 41% using OTC sleep aids for more than one year [1].While the Federal Drug Administration recognizes OTC Insomnia drugs of Benadryl (diphenhydramine) and Unisom (doxylamine), the marketing of other products fill pharmacy shelfs and offerings from online mailings [2]. Insomnia has been reported in some 30% of the general population based on large scale survey studies (Sleep In America Polls).Thus, the high need for a treatment to address the poor sleep quality of Insomnia is eminent. Measurements of OTC use of Sleep aids are survey are restricted to the reporting’s of the usage but not the reasons and ways in which the OTC sleep aids are used. Further, the measurement of possible complicating factors such as interaction effects with other medicines the patient is taking, the effectiveness of the OTC counter sleep aid, the aftereffects of the OTC sleep aids, and habit forming behaviours are reduced to reporting’s rather than measurement.","PeriodicalId":73946,"journal":{"name":"Journal of sleep disorders & therapy","volume":"7 1","pages":"1-1"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2167-0277.1000e143","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of sleep disorders & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0277.1000e143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
It is estimated that the some 18% of the population have taken an over-the-counter (OTC) sleep aid with some 41% using OTC sleep aids for more than one year [1].While the Federal Drug Administration recognizes OTC Insomnia drugs of Benadryl (diphenhydramine) and Unisom (doxylamine), the marketing of other products fill pharmacy shelfs and offerings from online mailings [2]. Insomnia has been reported in some 30% of the general population based on large scale survey studies (Sleep In America Polls).Thus, the high need for a treatment to address the poor sleep quality of Insomnia is eminent. Measurements of OTC use of Sleep aids are survey are restricted to the reporting’s of the usage but not the reasons and ways in which the OTC sleep aids are used. Further, the measurement of possible complicating factors such as interaction effects with other medicines the patient is taking, the effectiveness of the OTC counter sleep aid, the aftereffects of the OTC sleep aids, and habit forming behaviours are reduced to reporting’s rather than measurement.
据估计,约18%的人服用过非处方(OTC)助眠药,其中约41%的人使用OTC助眠药的时间超过一年。虽然联邦药物管理局承认非处方失眠药物苯海拉明(苯海拉明)和Unisom(多西克胺),但其他产品的市场营销充斥着药房的货架和在线邮件。根据大规模调查研究(Sleep in America Polls),大约30%的普通人群患有失眠症。因此,迫切需要一种治疗方法来解决失眠患者睡眠质量差的问题。对非处方助眠剂使用情况的调查仅限于报告使用情况,而不包括使用非处方助眠剂的原因和方式。此外,对可能的复杂因素的测量,如与患者正在服用的其他药物的相互作用,非处方助眠药的有效性,非处方助眠药的副作用,以及习惯形成行为的测量被减少到报告而不是测量。